Back to All Studies

Immune-mediated hemolytic anemia (IMHA) is a serious blood disorder that causes the body to destroy its own red blood cells. Previously funded work identified a safe and promising drug to treat IMHA in dogs. In this study, researchers will further investigate the efficacy of this drug in a clinical trial of client-owned dogs with IMHA. If successful, this would be a major step toward a new drug to treat this deadly disease.

Study ID
Study Status
Start Date
Grant amount awarded
Grant recipient
Cornell University
Study country
United States
Robert Goggs, BVSc, PhD
Study category
Hematology (Blood)